A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack(Mayo Clinic), Bruno Dubois(Portland State University), Kaj Blennow(Sahlgrenska University Hospital), Philip Scheltens(Inserm), María C. Carrillo(Alzheimer's Association), Harald Hampel(Inserm), Reisa A. Sperling(Brigham and Women's Hospital), Ronald C. Petersen(Mayo Clinic), Giovanni B. Frisoni(University of Geneva), David S. Knopman(Mayo Clinic), William J. Jagust(Lawrence Berkeley National Laboratory), Keith A. Johnson(Jacobson Holman (United States)), Howard Feldman(University of British Columbia), David A. Bennett(Rush University Medical Center)
Cited by 1,886
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k